NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
6.21
+0.90 (16.95%)
May 7, 2026, 12:01 PM EDT - Market open
NTHI Revenue
In the year 2025, NeOnc Technologies Holdings had annual revenue of $39.99K, down -51.82%.
Revenue (ttm)
$39.99K
Revenue Growth
-51.82%
P/S Ratio
3,344.71
Revenue / Employee
$7,998
Employees
5
Market Cap
156.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 39.99K | -43.01K | -51.82% |
| Dec 31, 2024 | 83.00K | 12.54K | 17.79% |
| Dec 31, 2023 | 70.46K | 50.46K | 252.31% |
| Dec 31, 2022 | 20.00K | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Verrica Pharmaceuticals | 35.58M |
| Cue Biopharma | 27.47M |
| Innate Pharma | 10.57M |
| Equillium | 4.39M |
| Cibus | 3.64M |
| Genelux | 8.00K |
NTHI News
- 3 hours ago - Biotech's Next Wave May Already be in Motion - GlobeNewsWire
- 1 day ago - Where Executives Are Doubling Down on Their Companies' Fortunes - GlobeNewsWire
- 2 days ago - NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts - GlobeNewsWire
- 13 days ago - NeOnc Technologies initiated with a Buy at BTIG - TheFly
- 26 days ago - NeOnc Technologies files to sell 680,558 shares of common stock for holders - TheFly
- 4 weeks ago - NeOnc Technologies files $300M mixed securities shelf - TheFly
- 5 weeks ago - NeOnc Provides Business Update and Reports Q4 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - NeOnc Technologies appoints Choi as Chief Accounting Officer - TheFly